Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis and stroke management

G J del Zoppo1

  • 1Scripps Clinic and Research Institute, La Jolla, Calif.

Hospital Practice (Office Ed.)
|November 15, 1993
PubMed
Summary
This summary is machine-generated.

Clot lysis therapy is suitable for up to 90% of occlusive stroke patients, with early intervention significantly improving outcomes. Concerns about hemorrhage risk from lysis appear unfounded, warranting further study into optimal treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombolytic therapy in acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Approach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same author

The neurovascular unit in the setting of stroke.

Journal of internal medicine·2010
Same author

Inflammation and the neurovascular unit in the setting of focal cerebral ischemia.

Neuroscience·2008
Same author

Vascular matrix adhesion and the blood-brain barrier.

Biochemical Society transactions·2006
Same author

Focal cerebral ischemia and hemostasis: a PAI-1 conundrum.

Journal of thrombosis and haemostasis : JTH·2005
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Medical Interventions

Background:

  • Occlusive stroke affects a significant patient population, necessitating effective treatment options.
  • Thrombolytic therapy (clot lysis) offers a potential treatment for ischemic stroke.
  • Previous concerns existed regarding the safety of thrombolysis due to potential hemorrhage risks.

Purpose of the Study:

  • To evaluate the candidacy of occlusive stroke patients for clot lysis therapy.
  • To assess the safety profile of clot lysis, specifically regarding hemorrhage.
  • To determine the impact of intervention timing on patient outcomes.

Main Methods:

  • Analysis of patient data to identify candidates for clot lysis.
  • Review of clinical outcomes and adverse events associated with thrombolysis.

Related Experiment Videos

  • Exploration of factors influencing treatment efficacy, including diagnostic efficiency and administration routes (intravenous vs. intra-arterial).

    • Main Results:

    • Up to 90% of patients with occlusive stroke may be candidates for clot lysis.
    • The risk of hemorrhage associated with clot lysis appears to be unwarranted.
    • Earlier intervention is strongly correlated with better patient outcomes.

    Conclusions:

    • Clot lysis is a viable and potentially widespread treatment for occlusive stroke.
    • The benefits of timely thrombolytic therapy outweigh the perceived risks of hemorrhage.
    • Ongoing research is crucial to optimize diagnostic methods, identify ideal treatment sites, and compare administration routes for clot lysis.